Industry Leaders’ Fireside Chat – Accelerating the Potential of Adoptive T-Cell Therapy to Drive Toward Approved Cell Therapies in Solid Tumors: Discussing the Past, Present & Future for TIL
Time: 8:50 am
day: Day One
Details:
TIL therapies have come a long way since the pioneering work of Dr Rosenberg in the late 80s and the opportunity TIL provides to improve and expand on current immunotherapeutic treatments holds a great deal of promise. Key themes and questions to be explored include:
•Discussing the key lessons learned from past developments to apply to current research
• Debating the role of Tumor Infiltrating Lymphocytes in the Checkpoint Inhibitor era
• Providing input on next generation technologies to drive the field forward
• Asking the question: ‘What lies on the horizon for TIL?’ and discussing the future to tackle colder tumors and drive the commercialization of TIL therapies
